openPR Logo
Press release

SMi’s Drug Discovery Chemistry announces key industry speakers and agenda released

11-22-2018 07:52 PM CET | Health & Medicine

Press release from: SMi Group

drug discovery, chemistry, AI, artificial intelligence,

drug discovery, chemistry, AI, artificial intelligence,

SMi’s Pharma is proud to announce the 3rd Annual Drug Discovery Chemistry Conference is back and the conference is taking place at the Copthorne Tara Hotel in London, UK on 18th and 19st March 2019.

This year’s event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines, with optimization of the R&D process to become cheaper, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery at present, as the process is overall long, expensive and often potential drugs will fail late in clinical trials, wasting resources and time.

SMi is proud to announce the Co-Chairs for the conference Roderick Hubbard, Professor, University of York, and Senior Fellow, Vernalis Research and Darren Green, Director of Molecular Design, GSK

Roderick Hubbard, Senior Fellow, University of York & Vernalis Research Ltd
Rod Hubbard has been an academic at York for over 35 years working with methods for analysis and exploitation of protein structure, developing molecular graphics and modelling methods in the 1980s and building Structural Biology at York during the 1980s and 1990s. In 1997, he was a founding SAB member of what became Vernalis. Since 2001 he has split his time between Vernalis (fragment and structure based drug discovery) and York (fragment methods for chemical biology and industrial biotechnology). In addition, he works with UK Research Councils and consults with pharmaceutical and technology companies around the world.

Darren Green, Director of Molecular Design, GlaxoSmithKline plc
Darren Green is Director of Molecular Design, GlaxoSmithKline. Based at Stevenage, his group specialises in the application of computational chemistry, machine learning and chemoinformatics methods to drug discovery. Darren also leads the GSK-ex scientia collaboration.
Darren has a PhD in Theoretical Chemistry from the University of Manchester and is a Fellow of the Royal Society of Chemistry.

Key Expert Speakers include:
• Tobias Gabriel, Global Head of External Drug Discovery, Novartis

• Markus Queisser, Scientific Leader, GlaxoSmithKline

• Andrew Popplewell, Head of Antibody Discovery & Engineering, UCB

• Hasane Ratni, Expert Scientist, F Hoffmann-La Roche

• Helmut Thomas, President and CEO, Cylenium Pharma

• Frederic Berst, Senior Investigator, Novartis

• Phil Cox, Senior Principal Research Scientist, AbbVie

• Christine Prosser, Principal Scientist, UCB

• Ulrich Schopfer, Head of Integrated Target & Lead Discovery, Novartis

• Edgar Jacoby, Senior Principal Scientist Computational Chemistry, Janssen

• Roland Burli, Senior Director, Head of Medicinal Chemistry, AstraZeneca

• Vivek Vishnudas, Sr Vice President Drug Discovery & Platform Sciences, Berg LLC

• James Dale, Senior Scientist and Head of Chemistry, Nanna Therapeutics

• Govinda Bhisetti, Principal Investigator & Head of Computational Chemistry, Biogen

• Chris Tame, Research Leader, BenevolentAI

• Graham Simpson, Head of Drug Discovery, GTN

• Alexander Hillisch, Director, Medicinal Chemistry, Bayer

• Dr Nick Camp, Drug Discovery Consultant, Nick Camp Consulting

To view the full speaker line-up and 2-day agenda please click on this link:
www.drug-discovery.co.uk/PR1

The conference also has an interactive half day pre conference workshop, which provide extra value to the Drug Discovery Chemistry conference, taking place on Wednesday 20 March 2019 at the same venue.
Morning Workshop: Artificial Intelligence in Drug Discovery
Workshop Leader: Dr Nick Camp, Drug Discovery Consultant, Nick Camp Consulting

If you are interested in participating and attending the conference, you can register at www.drug-discovery.co.uk/PR1 and save £400.

Interested in sponsoring, exhibiting or speaking at this event?Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Drug Discovery Chemistry Conference 2019
18 & 19 March 2019
Copthorne Tara Hotel, London, UK
www.drug-discovery.co.uk/PR1

Follow us @SMiPharm
#SMiDrugDischem

---- END ----
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Marketing Dept, 1st Floor
1 Westminster Bridge Road

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMi’s Drug Discovery Chemistry announces key industry speakers and agenda released here

News-ID: 1393150 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Discovery

Electronic Discovery Market Will Hit Big Revenues In Future | Conduent, Advanced …
Advance Market Analytics published a new research publication on “Global Electronic Discovery Market Insights, to 2027” with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Electronic Discovery market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled
Global Drug Discovery Market
Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents. Highlighted with 86 tables and 97 figures, this 181-page report Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule,
E-Discovery Market Future Prospects 2026 | Logikcull, Advanced Discovery, Cloudn …
The latest update of Global E-Discovery Market study provides comprehensive information on the development activities by industry players, growth opportunities and market sizing for E-Discovery, complete with analysis by key segments, leading and emerging players, and geographies. The 110 page study covers the detailed business overview of each profiled players, its complete research and market development history with latest news and press releases. The study helps in identifying and tracking
Computer-Aided Drug Discovery: Initiating a Paradigm Shift in Drug Discovery Ind …
The computer-aided drug design (CADD) is amalgamated with wet-lab techniques to clarify the mechanism of drug resistance, to search for new antibiotic targets and to design new and original antibiotics for both existing and new targets. CADD process can produce an atomic level structure-activity relationship (SAR) which is used to facilitate the drug design process thus curtailing both time and costs. According to a study conducted by Research Dive, the global
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Data Discovery Market Data Discovery Market Current Trends,Issues And Challenges
During the last decade, Technologies have evolved rapidly and huge volume of data about the customers is collected daily which can be transformed to useful information by using correct set of data discovery tools. The data discovery tools are a subsidiary of the business intelligence tools, which can provide the users with the possibility of building queries and finding the answers to these spontaneous queries. The data discovery tools need